Ceramide Signaling in the Regulation of Head & Neck Cancer Cell Death and Therapy
头部调节中的神经酰胺信号传导
基本信息
- 批准号:9930853
- 负责人:
- 金额:$ 1.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-07 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAutophagosomeCell DeathCell TherapyCellular StressCeramidesCisplatinComplexDataDevelopmentGenerationsGeneticGoalsHead and Neck CancerHead and Neck Squamous Cell CarcinomaHuman PapillomavirusHuman papilloma virus infectionHuman papillomavirus 16LinkLipidsMalignant Epithelial CellMediatingMetabolismMitochondriaMolecularOxidative StressPathogenesisPatientsPharmaceutical PreparationsPharmacologyPlayPositioning AttributeProtein p53ProteinsPublishingRegulationRoleSignal PathwaySignal TransductionSphingolipidsTestingTherapeuticTumor SuppressionTumor TissueVirusbasechemotherapydesigndihydroceramide desaturasegemcitabineimprovedmitochondrial autophagynovelnovel strategiesrecruitresponsetherapy outcometooltumortumorigenesis
项目摘要
SUMMARY
Human papilloma virus (HPV) plays major roles in head and neck squamous cell carcinoma (HNSCC)
pathogenesis. Paradoxically, HPV(+) HNSCC patients respond better to chemotherapy, such as cisplatin
(CDDP), compared to HPV(-) HNSCC patients. However, molecular mechanisms and signaling pathways
involved in HPV-mediated chemosensitivity are largely unknown. Thus, the overall goal of this application is to
define the mechanisms involved in chemosensitivity of HNSCC cells in response to HPV infection with regard
to ceramide metabolism and signaling. Our therapeutic goal is to utilize this mechanistic information for the
development of novel strategies to enhance chemotherapy-induced HNSCC cell death and tumor suppression
without HPV infection. Based on our novel and unpublished preliminary data, we propose a novel hypothesis
that HPV16-E7 enhances CerS1/C18-ceramide-dependent lethal mitophagy in response to chemotherapy-
induced cellular stress signaling, leading to enhanced HNSCC cell death and tumor suppression. This
hypothesis will be tested in three Specific Aims: 1) Determine the roles of HPV16-E6 versus HPV16-E7 in the
regulation of ceramide-mediated lethal mitophagy; 2) Determine the mechanisms by which HPV16-E7
signaling enhances ceramide-dependent lethal mitophagy; and 3) Define the therapeutic roles and
mechanisms of HPV16-E7 signaling in the regulation of ceramide-dependent lethal mitophagy and HNSCC
tumor suppression. Overall, these studies will help develop mechanism-based therapeutic strategies to induce
HPV16-E7/C18-ceramide-mediated lethal mitophagy signaling for improving tumor suppression by
chemotherapy in HNSCC patients.
总结
人乳头瘤病毒(HPV)在头颈部鳞状细胞癌(HNSCC)中起主要作用
发病机制特别是,HPV(+)HNSCC患者对化疗反应更好,如顺铂
(CDDP),与HPV(-)HNSCC患者相比。然而,分子机制和信号通路
参与HPV介导的化学敏感性的基因在很大程度上是未知的。因此,本申请的总体目标是
确定HNSCC细胞对HPV感染的化学敏感性的机制,
神经酰胺代谢和信号传导。我们的治疗目标是利用这种机制信息,
开发新的策略以增强化疗诱导的HNSCC细胞死亡和肿瘤抑制
没有HPV感染。基于我们新的和未发表的初步数据,我们提出了一个新的假设
HPV 16-E7增强CerS 1/C18-神经酰胺依赖性致死性线粒体自噬对化疗的反应-
诱导细胞应激信号传导,导致增强的HNSCC细胞死亡和肿瘤抑制。这
将在三个特定目的中检验假设:1)确定HPV 16-E6与HPV 16-E7在
神经酰胺介导的致死性线粒体自噬的调节; 2)确定HPV 16-E7
信号传导增强神经酰胺依赖性致死性线粒体自噬;和3)定义治疗作用,
HPV 16-E7信号在神经酰胺依赖性致死性线粒体自噬和HNSCC中的调控机制
肿瘤抑制总的来说,这些研究将有助于开发基于机制的治疗策略,
HPV 16-E7/C18-神经酰胺介导的致死性线粒体自噬信号通过增强肿瘤抑制作用
HNSCC患者的化疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Besim Ogretmen其他文献
Besim Ogretmen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Besim Ogretmen', 18)}}的其他基金
Sphingolipid Metabolism and Signaling in the Regulation of Senescence and Aging
鞘脂代谢和信号传导在衰老和衰老调节中的作用
- 批准号:
10253130 - 财政年份:2020
- 资助金额:
$ 1.62万 - 项目类别:
Ceramide metabolism and the regulation of TGF-beta receptor signaling to control metastasis
神经酰胺代谢和调节 TGF-β 受体信号传导以控制转移
- 批准号:
10411382 - 财政年份:2018
- 资助金额:
$ 1.62万 - 项目类别:
Ceramide metabolism and the regulation of PD-L1 signaling to control metastasis and resistance to immunotherapy in TNBC
神经酰胺代谢和 PD-L1 信号调节以控制 TNBC 的转移和免疫治疗耐药
- 批准号:
10801345 - 财政年份:2018
- 资助金额:
$ 1.62万 - 项目类别:
Ceramide metabolism and the regulation of TGF-beta receptor signaling to control metastasis
神经酰胺代谢和调节 TGF-β 受体信号传导以控制转移
- 批准号:
9977980 - 财政年份:2018
- 资助金额:
$ 1.62万 - 项目类别:
Ceramide metabolism and the regulation of TGF-beta receptor signaling to control metastasis
神经酰胺代谢和调节 TGF-β 受体信号传导以控制转移
- 批准号:
10222592 - 财政年份:2018
- 资助金额:
$ 1.62万 - 项目类别:
Ceramide metabolism and the regulation of TGF-beta receptor signaling to control metastasis
神经酰胺代谢和调节 TGF-β 受体信号传导以控制转移
- 批准号:
10460230 - 财政年份:2018
- 资助金额:
$ 1.62万 - 项目类别:
Ceramide metabolism and the regulation of TGF-beta receptor signaling to control metastasis
神经酰胺代谢和调节 TGF-β 受体信号传导以控制转移
- 批准号:
9441547 - 财政年份:2018
- 资助金额:
$ 1.62万 - 项目类别:
Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling
通过靶向鞘脂信号传导开发新型癌症疗法
- 批准号:
9072008 - 财政年份:2016
- 资助金额:
$ 1.62万 - 项目类别:
Project 2: Regulation of Tumor Metastasis by Systemic S1P and Complement Signaling
项目2:系统性S1P和补体信号调节肿瘤转移
- 批准号:
9072014 - 财政年份:2016
- 资助金额:
$ 1.62万 - 项目类别:
相似海外基金
ATG2 transfers lipids from ER exit site membranes to directly expand the growing autophagosome
ATG2 从 ER 出口位点膜转移脂质以直接扩展生长中的自噬体
- 批准号:
10707025 - 财政年份:2022
- 资助金额:
$ 1.62万 - 项目类别:
ATG2 transfers lipids from ER exit site membranes to directly expand the growing autophagosome
ATG2 从 ER 出口位点膜转移脂质以直接扩展生长中的自噬体
- 批准号:
10536404 - 财政年份:2022
- 资助金额:
$ 1.62万 - 项目类别:
ATG9 scrambles lipids in concert with ATG2 lipid delivery to directly grow the autophagosome
ATG9 与 ATG2 脂质输送协同扰乱脂质,以直接生长自噬体
- 批准号:
10247303 - 财政年份:2021
- 资助金额:
$ 1.62万 - 项目类别:
ATG9 scrambles lipids in concert with ATG2 lipid delivery to directly grow the autophagosome
ATG9 与 ATG2 脂质输送协同扰乱脂质,以直接生长自噬体
- 批准号:
10391326 - 财政年份:2021
- 资助金额:
$ 1.62万 - 项目类别:
Mechanism of initiating autophagosome biogenesis on ER membrane (P19)
内质网膜上自噬体生物发生的启动机制(P19)
- 批准号:
436808296 - 财政年份:2020
- 资助金额:
$ 1.62万 - 项目类别:
Collaborative Research Centres
Lipid flux during autophagosome membrane biogenesis
自噬体膜生物发生过程中的脂质通量
- 批准号:
10331030 - 财政年份:2020
- 资助金额:
$ 1.62万 - 项目类别:
Lipid flux during autophagosome membrane biogenesis
自噬体膜生物发生过程中的脂质通量
- 批准号:
10561660 - 财政年份:2020
- 资助金额:
$ 1.62万 - 项目类别:
The origin of autophagosome derived from the endoplasmic reticulum with a focus on pancreatic stellate cell activation genes
自噬体起源于内质网,重点关注胰腺星状细胞激活基因
- 批准号:
20K09036 - 财政年份:2020
- 资助金额:
$ 1.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
High-speed AFM observation of autophagosome formation sites formed by liquid-liquid phase separation
高速AFM观察液-液相分离形成的自噬体形成位点
- 批准号:
19K16344 - 财政年份:2019
- 资助金额:
$ 1.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of autophagosome formation in myelodysplastic syndrome
骨髓增生异常综合征自噬体形成分析
- 批准号:
19K16582 - 财政年份:2019
- 资助金额:
$ 1.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists